Verification of foetal Down syndrome biomarker proteins in maternal plasma and applications in prenatal screening for Down syndrome

Verification of foetal Down syndrome biomarker proteins in maternal plasma and applications in prenatal screening for Down syndrome

Abstract Background Down Syndrome (DS) has a very high morbidity, according to statistics, the incidence rate of DS is as high as 1:700 among the new born babies. At present, there are still no effective prevention or treatment methods for the disease. We used a Western Blot technique to validate di...

Full description

Bibliographic Details
Main Authors: Weiguo Sui, Qing Gan, Wei Wei Gong, Xiaolian Wei, Minglin Ou, Donge Tang, Huanyun Jing, Hua Lin, Yue Zhang, Yong Dai
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Translational Medicine Communications
Subjects:
Biomarkers
Down’s syndrome
Maternal blood plasma
Prenatal screening
Western blot
Online Access:http://link.springer.com/article/10.1186/s41231-018-0028-x

Internet

http://link.springer.com/article/10.1186/s41231-018-0028-x

Similar Items